hoonbae jeon, md curriculum vitae

Hoonbae Jeon, M.D. Curriculum Vitae

Hoonbae Jeon, M.D., F.A.C.S. Professor of Surgery

Tulane University

Office Address: Department of Surgery 1415 Tulane Avenue #HC-5 New Orleans, LA 70112-2632

Office Telephone and FAX (504)988 0783 phone (504)988 7510 fax Email : [email protected]

EDUCATION

03/01/1983-02/28/ 1985

Premedical Course, College of Natural Science Korea University, Seoul, Korea

03.01.1985-02.28.1990

M.D. College of Medicine Korea University, Seoul, Korea

03.01.1991-02.28.1995

Ph.D. Graduate School Korea University, Seoul, Korea

POSTGRADUATE TRAINING

03.01.1990-02.28.1991

Rotating Intern Korea University Medical Center, Korea University, Seoul, Korea

03.01.1991-02.28.1995

Resident General Surgery Korea University Medical Center Korea University, Seoul, Korea

03.01.1996-02.28.1998

Fellow Division of Hepatobiliary & Pancreatic Surgery Department of Surgery Asan Medical Center, University of Ulsan, Seoul, Korea

07.01.2000-06.30.2001

Fellow Abdominal Organ Transplantation Recanati/Miller Transplant Institute Mount Sinai Medical Center, Mount Sinai School of Medicine, New York University New York, New York

07.01.2001-06.30.2003

Fellow Abdominal Organ Transplantation

/30 3/1/17


Albert Einstein Medical Center, Jefferson Medical College, Thomas Jefferson University Philadelphia, Pennsylvania

LICENSURE AND CERTIFICATIONS 03.1990 - present National Medial Licensure of Korea (No.

40402) Ministry of Health and Welfare, Republic of Korea

03. 1995 - present Foreign Board Certified in General Surgery (No.3463) by Korean Surgical Society and Ministry of Health and Welfare, Republic of Korea

10. 1997 (Indefinitely valid) ECFMG Certificate (No. 0-439-076-1)

11. 2002 USMLE step III

2000 - 2002 New York – currently inactive

2001 - 2003 Pennsylvania – currently inactive

06.2003 ASTS Certification of Transplant Fellowship

09.2003 – 02.2011 Kentucky (No. 38247) – currently inactive

01.2009 - present Illinois (No. 336.083973) - active

03.2010 – 02.2017 Primary liver / living donor liver transplant surgeon at University of Illinois Hospital (ILUI) registered to UNOS

09.2012 ASTS Leadership Development Program Kellogg School of Management Northwestern University

09.2013-04.2014

Teaching Excellence Faculty Fellowship Department of Medical Education, College of Medicine, University of Illinois at Chicago

02.2017 Louisiana (304568) - active

/30 3/1/17


HOSPITAL PREVILLEGE 03.2017 – present Tulane University Medical Center

New Orleans, LA 5. 2009 – 2.2017 University of Illinois Hospital at Chicago

Chicago, IL 12. 2009 – 9.2013 Mount Sinai Medical Center

Chicago, IL 9. 2003 – 4.2009 Albert B. Chandler Medical Center, University of Kentucky

Lexington, KY

PRESENT POSITION 3. 2017 – present Professor of Surgery Department of Surgery

Tulane University School of Medicine New Orleans, LA

3. 2017 – present Surgical Director, Liver Transplant Program

Tulane University Medical Center New Orleans, LA

5. 2007 - present Adjunct Professor of Surgery

Department of Surgery Korea University College of Medicine Seoul, Korea

PREVIOUS POSITIONS 5. 2009 – 2. 2017 Associate Professor of Surgery

University of Illinois at Chicago College of Medicine Chicago, Illinois

5. 2009 – 2. 2017 Surgical Director, Liver Transplant Program

University of Illinois Hospital Chicago, Illinois

5. 2009 – 2. 2017 Director, Transplant Surgery Fellowship Program

University of Illinois at Chicago College of Medicine Chicago, Illinois (Previous Trainees: Chandra Bhati, MD Atul Nanda, MD Arshad Khan, MD)

09.22.2003 - 04.30.2009

Assistant Professor of Surgery

Department of Surgery University of Kentucky College of Medicine, Lexington, Kentucky

/30 3/1/17


09.22.2003 - 04.30.2009

Transplant Surgeon University of Kentucky Transplant Center Albert B. Chandler Medical Center Lexington, Kentucky

07.01.2001 -06.30. 2003

Clinical Instructor Department of Surgery Albert Einstein Medical Center Jefferson Medical College, Thomas Jefferson University Philadelphia, Pennsylvania

03.01 2000 -6.30. 2000

Assistant Professor of Surgery

Department of Surgery Soonchunhyang University College of Medicine Seoul, Korea

03.01.1998 -02.28.2000

Instructor in Surgery Department of Surgery Soonchunhyang University College of Medicine Seoul, Korea

03.01.1998 -06.30.2000

Attending Hepatobiliary Surgeon

Soonchunhyang University Hospital Seoul, Korea

03.01.1998 -06.30.2000

Surgical Consultant International Clinic, Soonchunhyang University Hospital, Seoul, Korea (A primary care facility for foreign nationals in Seoul, Korea)

03.01.1995 -02.28.1996

Clinical Instructor in Surgery

Korea University College of Medicine Seoul, Korea

AWARD AND HONORS

05.2013 The Maurice F. Rabb, MD/Jose F. Pulido, MD Award (Teaching award selected by class of 2013) College of Medicine, University of Illinois at Chicago

12. 2008 Faculty teaching award, Department of Surgery, College of Medicine, University of Kentucky

10.1999–11.1999

German Academic Exchange Service Scholar (Deutche Akademischer Austausch Dienst: DAAD) Department of Transplantation, Goettingen University - Professor Dr. med. Burckhard Ringe

PROFESSIONAL MEMBERSHIPS 2012 – present American Hepatopancreatobiliary Association

/30 3/1/17


2010 – present Clinical Robotic Surgery Association

2009 – present Illinois Medical Association

2009 - present Warren H. Cole Society

2007 – present Fellow, American College of Surgeons

2006 – present American Association for Study of Liver Disease

2004 - present Fellow, International College of Surgery

2003 - present American Society of Transplant Surgeons

1999 - present International Liver Transplantation Society

1997 - present Asian Society of Hepatobiliary and Pancreatic Surgery

1995 - present Korean Surgical Society

1990 - present Korean Medical Association

COMMITTEES ACTIVE

06.2012 – present Membership Committee, American Society of Transplant Surgeons

06.2012 - present International Relation Committee, American Hepatopancreatobiliary Association

03.2017 – present Chairperson, Liver transplantation patient review committee, Tulane University Medical Center, New Orleans

03.2017 – present Kidney and pancreas transplantation patient review committee, Tulane University Medical Center, New Orleans

07.2017 - present Excecutive Board, Louisiana Organ Procurement Agency, Metarie, Louisiana

PAST 07.2016 – 02.2017 Associate councilor/Councilor elect, UNOS Region 7 (2016 – 2019)

Membership and professional standard committee, UNOS/OPTN

10.2013-02.2017 Curriculum Committee, College of Medicine, University of Illinois at Chicago

09.2013-02.2017 Co-director, Combined Radiology-Surgery-Anatomy course for 4th

year medical students, College of Medicine, University of Illinois at Chicago (A new course which was launched in early 2015)

/30 3/1/17


05.2013 – 02.2017 Liver Transplantation Subcommittee, Gift of Hope Organ and Tissue Donor Network, Itasca, IL

05.2011 – 02.2017 Transfusion Practice Committee, University of Illinois Hospital, Chicago

02. 2010 – 02.2017 Chairperson, Kidney organ procurement and distribution committee, Gift of Hope Organ and Tissue Donor Network, Itasca, IL

08.2009 – 02.2017 Resident and Award Committee, Department of Surgery, College of Medicine, University of Illinois at Chicago

07.2009 – 02.2017 Liver Transplantation Review Board, UNOS Region 7

02.2013 – 08.2013 Search Committee for Division Chief of Gastroenterology, College of Medicine, University of Illinois at Chicago

12.2011 – 02.2013 Hospital Throughput Committee, University of Illinois Hospital, Chicago

11. 2009 – 06.2011 Chairperson, Donation after cardiac death task force, Gift of Hope Organ and Tissue Donor Network, Itasca, IL

10.2009 – 06.2011 QA Committee, Department of Surgery, College of Medicine, University of Illinois at Chicago

06.2008 – 05.2012 Winter Symposium Planning Committee, American Society of Transplant Surgeons

06.2008 – 05.2011 Vanguard Committee, American Society of Transplant Surgeons

03. 2008 - 04.2009 Task force for end-stage liver disease service, University of Kentucky College of Medicine, Lexington, KY

01.2008 – 01.2011 Continuous Medical Education Committee, International College of Surgeons

09. 2003 - 04. 2009 Kidney and Pancreas Transplant Evaluation Committee, University of Kentucky College of Medicine, Lexington, KY

09. 2003 – 04. 2009 Liver Transplant Evaluation Committee, University of Kentucky College of Medicine, Lexington, KY

09. 2003 – 03. 2007 Transplantation Steering Committee University of Kentucky College of Medicine, Lexington, KY

11.1999 - 6.2000 Organ Transplantation Committee, Soonchunhyang University College of Medicine, Seoul, Korea

9.1999 - 6.2000 Task Force for Faculty Evaluation Standard Development, Soonchunhyang University College of Medicine, Seoul, Korea

/30 3/1/17


8.1998 - 6.2000 Co-Chair, Hospital Nutrition Committee, Soonchunhyang University College of Medicine, Seoul, Korea

11.1998 - 6.2000 Residency Program Review Committee, Korean Surgical Society

11. 1996 - 10. 1998 Editorial Committee, Korean Surgical Society

3.1994 - 2.1995 Chairperson, Committee of Chief Residents, Korea University College of Medicine, Seoul, Korea

EDITORIAL ACTIVITIES

08.2016 – present Editor, Korean Journal of Hepatobiliary and pancreas surgery

01.2016 – present Peer Reviewer, World Journal of Surgery

05.2014 – present Peer Reviewer, JAMA Surgery

01.2013 – present Peer Reviewer, Transplantation

01.2012 – present Peer Reviewer, Mount Sinai Journal of Medicine

12.2011 – present Peer Reviewer, International Journal of Gastrointestinal Cancer

03.2011 – 04.2014 Associate Editor, BMC Gastroenterology

07.2010 – present Peer reviewer, American Journal of Surgery

10.2008 – 10.2011 Abstract Reviewer, Winter Symposium, American Society of Transplant Surgeons

09. 2006 – present Peer reviewer, Liver Transplantation

11.1996 - 9.1998 Assistant Editor, Journal of Korean Surgical Society

RESEARCH Previous Projects 1. Co-Investigator, (PI: West-Thielke, P) A Phase 2a, Randomized, Open-Label, Active

Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de novo Kidney Transplant Recipients. Sponsor: Astellas, 2012- 2017, Amount: $380,000

2. Co-Investigator, (PI: West-Thielke, P) A Randomized, Open-label, Multicenter Trial to Determine Safety and Efficacy of Eculizumab in the Prevention of Antibody Mediated Rejection (AMR) in Living Donor Kidney Transplant Recipients Requiring Desensitization Therapy Study Number: C10-001. Sponsor: Alexion, 2012-2017, Amount: $268,000

/30 3/1/17


3. Co-Investigator, (PI: West-Thielke, P) LCP-Tacro 3003 Switching Study of Kidney Transplant Patients with Tremor to LCP-TacrO (STRATO). Sponsor: Veloxis, 2011-2017, Amount: $48,000

4. Co-Investigator, (PI: West-Thielke, P) Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation. Sponsor: Quark, 2008-2017, Amount: $27,000

5. Co-Investigator, (PI: West-Thielke, P) A Phase 2, Double-Blind, Double-Dummy, Multi-Center, Prospective, Randomized Study of the Pharmacokinetics of LCP Tacro (TM) Tablets, Once Daily, Compared to Prograf(R) Capsules, Twice Daily, for the Prevention of Acute Allograft Rejection in De Novo Adult Kidney Transplant Recipients. Sponsor: Veloxis, 2012-2013, Amount: $87,000.

6. Co-Investigator, (PI: West-Thielke, P) A Phase 3, Double-Blind, Double-Dummy, Multi-Center, Prospective, Randomized Study of the Efficacy and Safety of LCP Tacro™ Tablets, Once Daily, Compared to Prograf® Capsules, Twice Daily, in Combination with Mycophenolate Mofetil for the Prevention of Acute Allograft Rejection in De Novo Adult Kidney Transplant Recipients. Sponssor: Veloxis, 2011-2013, Amount: $170,000

7. Co-Investigator, (PI: West-Thielke, P) A Phase 1b, Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Single-Dose, Pharmacokinetic, Safety and Tolerability Study of ASKP1240 in de Novo Kidney Transplantation. Sponsor: Astellas, 2009-2011, Amount: $43,000

8. Co-Investigator (PI: Oberholzer, J), 12 month, multi-center, randomized, open-label non-inferiority study comparing the safety and efficacy of concentration-controlled Everolimus with low dose tacrolimus to CellCept® (mycophenolate mofetil) with standard dose tacrolimus in de novo renal transplant recipients. Sponsor: Novartis, 2008-2010, Amount: $181,000

9. Co-Investigator, The Effects of Thymoglobulin on Immune Cell Function, 2010-2015 10. Co-Investigator, Determination of the effects of thymoglobulin dose adjustments on

renal transplant outcomes, 2011-2015 11. Co-Investigator, A Comparison of Alemtuzumab and Antithymocyte Globulin Induction

in High-Risk , Non-Sensitized Renal Transplant Recipients, 2013-2017 12. Co-Investigator, Limited Access Protocol for the Use of Oral Cisapride in the Treatment

of Refractory Gastroesophageal Reflux Disease and Other Gastrointestinal Motility Disorder - CIS-USA-154, 2012-2017

13. Co-Investigator, Abdominal Organ Preservation with Normothermic Recirculation in Potential Donors Expiring After Out-or-Hospital Cardiac Arrest, 2012-2017

14. Co-Investigator, Simultaneous Robotic Kidney Transplantation and Bariatric Surgery for Morbidly Obese Patients with End-Stage Renal Failure, 2012-2017

15. Co-Investigator, LCP-Tacro 3003 Switching Study of Kidney Transplant Patients with Tremor to LCP-TacrO (STRATO), 2012-2017

16. Co-Investigator, Racial Profile of Live Kidney Donations at UICMC from January 1, 2007 to May 31, 2012, 2012-2017

17. Co-Investigator, Evaluating Nulojix Long Term Safety in Transplant (ENLiST), 2012-2017 18. Co-Investigator, Retrospective/Prospective Study of Kidney Transplant Outcomes 1968

through Present, 2012-2017 19. Co-Investigator (PI: Oberholzer, J) “Islet Transplantation in Type 1 Diabetic Patients

Using the Edmonton Protocol of Steroid Free Immunosuppression. Protocol No. 2004-0532, 2009 - 2017

/30 3/1/17


20. Co-Investigator (PI: Oberholzer, J) “Islet Transplantation in Type 1 Diabetic Patients Using the UIC Protocol Phase 3 “Protocol No. 2007-0330, 2009 - 2017

21. Co-Investigator (PI: Tzvetanov, I) “Retrospective/Prospective Study of Small Bowel Transplant Outcomes” Protocol No. 2008-0070, 2009 - 2017

22. Primary Investigator “Retrospective/Prospective Study of Liver Transplant Outcomes January 1985 through Present” Protocol No.2008-0072, 2009 - 2017

23. Co-Investigator (PI: Oberholzer, J) Islet Transplantation in Type 1 Diabetic Kidney Allograft Recipients: Efficacy of Islet after Kidney Transplantation” Protocol No. 2008-0175, 2009 - 2017

24. Co-Investigator (PI: West-Thielke, P) Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation” Protocol No. 2008-1085, 2009 - 2017

25. Co-Investigator (PI: West-Thielke, J) Levofloxacin Prophylaxis for BK Viremia in Kidney Transplant Recipients” Protocol No. 2009-0019, 2009 - 2017

26. PI – Patricia West Thielke, Co-Investigator (PI: West-Thielke, P) A Collaborative Experience Using Bortezomib for the Treatment of Antibody Mediated Rejection in Solid Organ Transplantation” Protocol No. 2009-1213, 2009 – 2017

27. Co-Investigator (PI: West-Thielke, P) Analysis of Risk Factors for Long Term Outcomes of Kidney and/or SPK Transplant Recipients (OPTN)” Protocol No. 2010-0202, 2009 - 2017

28. Co-Investigator (PI: West-Thielke, P) Pancreas Transplant Outcomes: A Single Center Experience with Steroid Avoidance” Protocol No. 2010-0821, 2010 - 2017

29. Co-Investigator (PI: West-Thielke, P) A Randomized, Open-label, Multicenter Trial to Determine Safety and Efficacy of Eculizumab in the Prevention of Antibody Mediated Rejection (AMR) in Living Donor Kidney Transplant Recipients Requiring Desensitization Therapy Study Number: C10-001” Protocol No. 2011-0510, 2011 - 2017

30. Co-Investigator (PI: Benedetti, E) Randomized Case-Control Trial About the Impact of Targeted Physical Activity and Diet Modification on Obese Kidney Transplant Recipients' Outcome” Protocol No. 2011-0808, 2011 - 2017

31. Co-Investigator (Giulianotti, PC) Retrospective Study of Robotic Surgery Outcomes” Protocol No. 2011-1104, 2011 - 2017

32. Co-Investigator (PI: West-Thielke, P) LCP-Tacro 3003 Switching Study of Kidney Transplant Patients with Tremor to LCP-TacrO (STRATO)” Protocol No. 2012-0099, 2012 - 2017

33. Co-Investigator (PI: Oberholzer, J) Extended Follow Up after Islet Transplantation in Type I Diabetes, CIT-08” Protocol No. 2012-0834, 2012 - 2017

34. Co-Investigator (PI: West-Thielke, P) A Phase 2a, Randomized, Open-Label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de novo Kidney Transplant Recipients” Protocol No. 2012-1116, 2012 - 2017t

35. Co-Investigator (PI: Oberholzer, J)” A 12-month, Multi-center, Randomized, Open-label Non-inferiority Study Comparing the Safety and Efficacy of Concentration-controlled Everolimus with Low Dose Tacrolimus to CellCept (Mycophenolate Mofetil) with Standard Dose Tacrolimus in de Novo Renal Transplant Patients” Protocol No. 2010-0309, 2010 - 2012

36. Co-Investigator (PI: West-Thielke, P) A 12-month, Multi-center, Randomized, Open-label Non-inferiority Study Comparing the Safety and Efficacy of Concentration-controlled Everolimus with Low Dose Tacrolimus to CellCept (Mycophenolate Mofetil) with Standard Dose Tacrolimus in de Novo Renal Transplant Patients 2010

/30 3/1/17


37. Co-Investigator (PI: West-Thielke, P) A Phase 1b, Randomized , Double-Blind, Parallel Group, Placebo- Controlled, Single-Dose , Pharmacokinetic, Safety and Tolerability Study of ASKP 1240 in de Novo Kidney Transplantation 2010

38. Primary Investigator Efficacy of neoadjuvant chemo radiotherapy followed by liver transplantation for hilar cholangiocarcinoma; a multi-center review 2010

39. Co-Investigator (PI: Oberholzer, J) Extended Follow Up After Islet Transplantation in Type 1 Diabetes, CIT-08 2011

40. Co-Investigator (PI: West-Thielke, P)” A Phase 2, Double-Blind, Double-Dummy, Multi-Center, Prospective, Randomized Study of the Pharmacokinetics of LCP Tacro (TM) Tablets, Once Daily, Compared to Prograf(R) Capsules, Twice Daily, for the Prevention of Acute Allograft Rejection in De Novo Adult Kidney Transplant Recipients” Protocol No. 2012-0974

41. Co-Investigator (PI: West-Thielke, P)” The Effects of Thymoglobulin on Immune Cell Function” Protocol No. 2010-1013

42. Co-Investigator (PI: West-Thielke, P)” A Phase 3, Double-Blind, Double-Dummy, Multi-Center, Prospective, Randomized Study of the Efficacy and Safety of LCP-Tacro Tablets, Once Daily, Compared to Prograf Capsules, Twice Daily, in Combination with Mycophenolate Mofetil for the Prevention of Acute Allograft Rejection in De Novo Adult Kidney Transplant Recipients” Protocol No. 2011-0112

43. Co-Investigator (PI: Oberholzer, J)” A52 Week Randomised, Double-Blind, Placebo Controlled, Parallel Group, Multi-Centre, Multinational Exploratory Trial in Islet Cell Transplant Subjects With Type 1 Diabetes Mellitus to Evaluate The Early Use of Liraglutide As An Adjunct to Standard Care Regarding the Percentage of Subjects Achieving Insulin Independence After First Transplantation. Trial ID: NN2211-3619” Protocol No. 2011-1122

44. Primary Investigator “CellCept (mycophenolate mofetil) maintenance immunosuppression in liver transplant recipients with long-term follow-up posttransplantation of non-autoimmune lie r disease – A prospective, randomized, multicenter trial.”. Sponsor: Roche/Albert Einstein Medical Center. $ 37,298.74 Protocol No. CEL350, IRB 060892F1V

45. Co-Investigator (PI: Ranjan D) “A Randomized, Double-Blind Study to Assess the Efficacy and Safety of Prophylactic Use of Maribavir versus Oral Ganciclovir for the Prevention of Cytomegalovirus Disease in Recipients of Orthotopic Liver Transplants.” Sponsor: ViroPharma. $ 116,495, 07-0541-F6A

46. Co-Investigator (PI: Ranjan D) “A Randomized, Open- Label, Comparative Evaluation of Conversion from Calineurin Inhibitor Treatment Versus Continued Calineurin Inhibitor Treatment in Liver Allograft Recipients Undergoing Maintenance Therapy”. Sponsor: Wyeth Research. $263,193, 2002- Protocol 0468H1-316-US

47. Co-Investigator (PI: Johnston TD) “A Prospective, Randomized, Multi-Center Double-Blind Study of Early Corticosteroid Cessation vs. Long-Term Maintenance Corticosteroid Therapy with Zenapax, Prograf, and CellCept in Primary Renal Transplant Recipients.” Sponsor: Fujisawa Healthcare Incorporated Funding: $120,000 (projected) 6 subjects enrolled. Protocol Number 20-99-001.

48. Co-Investigator (PI: Johnston TD) “A 24-Month, Multicenter, Randomized, Open-Label Non-Inferiority Study of Efficacy and Safety Comparing Concentration-Controlled Certican® in Two Doses (1.5 and 3.0 mg/day Starting Doses) with Reduced Neoral® versus 1.44 Myfortic® with Standard Dose Neoral in de novo Renal Transplant Recipients (2309)” Sponsor: Novartis $ 339,206.63, 05-0639-F1V

/30 3/1/17


49. Co-Investigator (PI: Johnston TD) “A Facilitated Access Program to Provide Everolimus (RAD) for Maintenance Patients Completing Therapy in RAD Trials in Solid Organ Transplantation (2401)” Sponsor: Novartis $ 25,010, 76 07-0892-F6A

50. Co-Investigator (PI: Johnston TD) “Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (IM103-008)” Sponsor: BMS $ 253,525, 06-0436-F1V

51. Co-Investigator (PI: Johnston TD) “A Randomized, Open-Label, Multicenter, Parallel-Group Study of Belatacept-Based Corticosteroid-Free Regimens in Renal Transplant (IM103-034)” Sponsor: BMS $ 67,264 07-0661-F6A

52. Co-Investigator (PI: Johnston TD) “A 24-Month, Multicenter, Randomized, Open-Label Non-Inferiority Study of Efficacy and Safety Comparing Concentration-Controlled Certican® in Two Doses (1.5 and 3.0 mg/day Starting Doses) with Reduced Neoral® versus 1.44 Myfortic® with Standard Dose Neoral in de novo Renal Transplant Recipients (2309)” Sponsor: Novartis $ 339,206.63 05-0639-F1V

53. Co-Investigator (PI: Johnston TD) “A Randomized, Open-label, Study to Compare the Safety and Efficacy of Two Different Rapamune Regimens With A Tacrolimus+ Mycopheonlate Mofetil Regimen In De Novo Renal Allograft Recipients (ORION)” Sponsor: Wyeth $ 124,308 04-0387-F2L

54. Co-Investigator (PI: Johnston TD) “A Randomized, Open-Label, Comparative Evaluation of Conversion from Calcineurin Inhibitors to Sirolimus Versus Continued Use of Calcineurin Inhibitors in Renal Allograft Recipients (316)” Sponsor: Wyeth $ 225,900 03-0054-F3R

55. Primary Investigator “A Prospective, Randomized, Open-Label, Twenty-Six Week Study of the Efficacy and Safety of Converting Liver Transplant Recipients with Tacrolimus-Associated Abnormal Glucose Metabolism to Neoral with C2 Monitoring.” . Novartis Pharmaceuticals Corporation, 2003 Funding: $75,000 Projected enrollment: 10 Site initiated: 1/30/04 Currently enrolled: 2, Closed Protocol COLO 400A US 06

56. Co-Investigator. (PI: Sheiner P.) A Randomized, Open-Label Preference Study of Gengraf™ Compared to Neoral® in Stable Solid-Organ Transplant Subjects. GCO# 00-0454.Abbott Laboratories, $75,000.00 7/2000-6/2001

57. Co-Investigator (PI:Fishbein T.) A Randomized, Comparative Trial of Prograf (Tacrolimus) in Combination with Sirolimus or Mycophenolate Mofetil after Liver Transplantation. GCO# 00-0451.Fujisawa Health Care Inc. $80,000.00. 7/2000-6/2001

58. Co-Investigator (PI:Sheiner P.) A Prospective, Randomized, Multicenter, Open-Label, Comparative Safety and Efficacy Study of Prophylactically Administered Pegylated Interferon alfa-2a (Pegasys®) Plus Ribavirin vs. No Prophylaxis Following Liver Transplantation for Hepatitis C. National Institutes of Health. GCO # 99-1022. $352,464.00. 7/2000-6/2001

59. Co-Investigator (PI:Sheiner P.) Pilot Study to Assess the Pharmacokinetics of Intravenous Nabi 5%, Hepatitis B Immune Globulin (Boca HBVIg) Used in Combination with Lamivudine for Patients with Hepatitis B Virus (HBV) Associated Liver Disease Undergoing Liver Transplantation” Gco # 99-1005.Mayo Clinic. Total Grant $6,000.00 7/2000-6/2001

60. Co-Investigator (PI:Sheiner P.) The Pharmacokinetics and Safety of Boca HBVIg Given Intravenously to Patients Following Orthotopic Liver Transplantation for Chronic Hepatitis B. Nabi Pharmaceuticals. GCO # 99-0852.Total Grant: $57,600.00 7/2000-6/2001

/30 3/1/17


61. Co-Investigator (PI:Burrows L.)Prograf (tacrolimus) as Secondary Intervention vs. Continuation of Cyclosporine in Patients at Risk for Chronic Renal Allograft Failure. GCO# 99-0115. Fujisawa Health Care Inc. $18,000.00 7/2000-6/2001

62. Co-Investigator (PI: Bromberg J.)Multicenter, randomized, partially-blinded study of the safety and efficacy of FTY 720 combined with corticosteroids and full or reduced-dose Neoral in de novo adult renal transplant recipients. GCO# 00-0132 Novartis Pharmaceuticals: $ 85,000.00 7/2000-2/2001

63. Co-Investigator (PI: Emre S.) A multi-center, randomized, double-blind, parallel group, placebo-controlled dose exploratory trial evaluating the safety and effect of activated recombinant factor VIIa (rFVIIa/ NovoSeven®) in the prevention of bleeding in subjects undergoing orthotopic liver transplantation. GCO# 00-0002.NovoNordisk Pharmaceuticals. $ 200,000.00 7/2000-4/2001

64. Co-Investigator (PI: Bromberg J.) “A 1-Year, Multicenter, Single Arm, Open Label, Pilot Study of the Efficacy and Safety of RAD in de novo Renal Transplant Recipients At Immunological High Risk of Rejection”. GCO# 00-0181.Novartis Pharmaceuticals. $58,000.00 7/2000-6/2001

65. Co-Investigator. (PI: Sheiner P.) A Randomized, Open-Label Preference Study of Gengraf™ Compared to Neoral® in Stable Solid-Organ Transplant Subjects. GCO# 00-0454.Abbott Laboratories, $15,000.00 7/2000-6/2001

66. Co-Investigator (PI:Fishbein T.) A Randomized, Comparative Trial of Prograf (Tacrolimus) in Combination with Sirolimus or Mycophenolate Mofetil after Liver Transplantation. GCO# 00-0451.Fujisawa Health Care Inc. $80,000.00. 7/2000-6/2001

67. Co-Investigator (PI:Bromberg J.) Open-label, randomized, controlled multiple-dose study of efficacy and safety of BMS-224818 as part of a quadruple drug regimen in first renal transplant recipients. GCO# 00-1105. Bristol-Myers Squibb Pharmaceuticals: $245,000.00 7/2000-6/2001

68. Co-Investigator (PI: Emre S.) An Ascending, Single Dose, Safety, Tolerance, and Pharmacokinetic Study of Oral Sirolimus Solution (Rapamune) in Pediatric Patients with Stable Liver Allografts Receiving Daily Oral Doses of Tacrolimus. GCO# 00-0827.Wyeth Ayerst Pharmaceuticals. $153,350.00. 7/2000-6/2001

69. Co-Investigator (PI: Waid T) “A Phase II, Randomized, Multi-Center, Open-Label Safety Study of ISATX247 and Cyclosporine (Neoral) in Post-Renal Transplant Patients.” Sponsor: Isotechnika Incorporated, 2002. 2 subjects enrolled Funding: $35,433 Protocol ISA00-16. 8/2002-8/2004

70. Co-Investigator (PI: McKeown JW) “Diabetes Incidence after Renal Transplantation: Neoral C2 Monitoring versus Tacrolimus” Protocol Number OLO400A2419 Sponsor: Novartis Funding: $152,864.05 Patients Enrolled/Projected: 7/10 Open Date: 4/1/04 Closed

71. Co- Investigator (PI: Waid T) A Randomized, Open-Label Study to Compare the Safety and Efficacy of Two Different Rapamune Regimens With a Tacrolimus + Mycophenolate Mofetil Regimen in De Novo Renal Allograft Recipients. Sponsor: Wyeth Funding: $124,676.79 Patients Enrolled/Projected: 4/10 Open Date: 9-2-04 Closed Protocol Number 0468H1-101497

72. Co-Investigator (PI: Waid TD) “Prograf (tacrolimus) as Secondary Intervention vs. Continuation of Cyclosporine in Patients at Risk for Chronic Renal Allograft Failure.” Sponsor: Fujisawa Healthcare, Incorporated Funding: $138,425 32 subjects enrolled Open date: 5/3/99 (IRB approval) Closure date: 9/2005 (projected) Protocol 20-98-002.

/30 3/1/17


73. Co-Investigator (PI: Johnston TD) “A Phase III, Open-Label, Comparative, Multi-Center Study to Assess the Safety and Efficacy of Prograf (tacrolimus)/MMF, Modified Release (MR) Tacrolimus/MMF and Neoral (cyclosporine)/MMF in de novo Kidney Transplant Recipients.” Sponsor: Fujisawa Healthcare, Incorporated Funding: $292,890 10 subjects projected, 3 subjects enrolled Open date: 8/18/03 (IRB approval) Closure date: 8/2007 (projected) Protocol 02-0-158.

74. Co Investigator (PI: Johnston TD) An Open Label, Randomized, Multicenter Study To Evaluate The Efficacy and Safety of Early Calcineurin Inhibitor Withdrawal In Recipients Of Primary Renal Allografts Maintained Long-Term On Mycophenolate Mofetil and Sirolimus. Sponsor: Roche Laboratories. 2003- -$118,150 Protocol ML17140/01265

75. Co- Investigator (PI: West-Thielke, P) A Phase 2, Randomized, Open-Label, Parallel Group, Multi-Center Study to Assess the Safety and Efficacy of Alefacept in de novo Kidney Transplant Recipients. 2008 (Protocol 2008-0002)

76. Co- Investigator (PI: West-Thielke, P) A Phase 3, Open-Label, Multicenter, Prospective, Randomized Study of the Efficacy and Safety of Conversion From Prograf Capsules Twice Daily to LCP-TACRO Tablets Once Daily for the Prevention of Acute Allograft Rejection in Stable Kidney Transplant Patients (Protocol 2008-1091)

77. Co- Investigator (PI: West-Thielke, P) A Phase 1b, Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Single-Dose, Pharmacokinetic, Safety and Tolerability Study of ASKP1240 in de Novo Kidney Transplantation (Protocol 2010-0702)

MANUSCRIPTS PUBLISHED IN PEER-REVIEWED JOURNALS

1. Jeon H, Choi SY, Kim YC, Koo B: An Experimental study on the enhanced cytolytic effects of Natural Killer Cells by interleukin-2. Journal of Korean Surgical Society vol.45 no.3 pp.313-324. 1993

2. Jung SI, Jeon H, Lee ES, Nam YS, Hwang CW: Profundoplasty for combined aortoiliac and superficial femoral occlusive lesion. Journal of Korean Surgical Society vol.47 no.4 pp.565-573. 1994

3. Jeon H, Koo B, Chae Y: Relation between p53 overexpression and established prognostic factors in breast cancer. Journal of Korean Surgical Society vol.48 no.5 pp.648-660. 1995

4. Lee SD, Jeon H, Mok YJ, Choi SY, Moon H, Koo B: Experiences of hepatic resection after preoperative transarterial chemoembolization in hepatocellular carcinoma. Journal of Korean Surgical Society vol.50 no.3 pp.395-401. 1996

5. Kim C, Jeon H: Clinical experience of circumumbilical incision for infantile hypertrophic pyloric stenosis. Journal of Korean Association of Pediatric Surgeons vol.2 no.2. 1996

6. Lee YJ, Lee SG, Park KM, Hwang S, Nam CW, Jeon H, Lee SG, Kim MH, Min PC: Two cases of advanced mucin producing pancreatic tumor. Korean Journal of HBP Surgery vol.1 no.1 pp.155-160. 1997

7. Kim KM, Lee SG, Lee YJ, Park KM, Kim SC, Jeon H, Kwon SW, Han SH, Lee MG, Choi KT, Ha HS: Living related liver transplantation across ABO blood groups. Journal of Korean Society of Transplantation vol.11 no.1 pp.145-149. 1997

8. Kim CS, Jeon H, Ryu JW, Kim KH, Koo BH: The effect of surgical manipulation on the bacterial translocation from the gut. Journal of Korean Surgical Society vol.52 no.6 pp.790-795. 1997

/30 3/1/17


9. Lee YJ, Lee SG, Jeon H, Park K, Nam CW, Hwang S, Min PC: Anormalous vessels encountered during hepatoduodenal and/or aortocaval lymph node dissection. Journal of Korean Surgical Society vol.53 no.1 pp.105-110. 1997

10. Jeon H, Lee SG, Min PC: Experience of an en bloc resection of right lobe of liver, adrenal, kidney and infrahepatic vena cava with the aid of veno-venous bypass. Korean Journal of HBP Surgery vol.1 no.2 pp.171-177. 1997

11. Hwang S, Lee SG, Lee YJ, Park KM, Jeon H, Kim PN, Min PC : Calculation of standard liver volume of Korean adult. Korean Journal of HBP Surgery vol.1 no.2 pp.59-65. 1997

12. Jeon H, Cho YP, Lee SG, Lee YJ, Park KM, Choi KM, Hwang S, Min PC, Kim MH, Lee SG: Treatment of ampullary neoplasm, diagnosed as benign on preoperative endoscopic biopsy. Journal of Korean Surgical Society vol.53 no.2 pp.258-264. 1997

13. Park KM, Lee SG, Lee YJ, Jeon H, Hwang S, Choi KM, Kwon TW, Nam CW, Kim KM, Lee MG, Sung KB, Han SH, Ko KS, Choi KT, You ES, Oh WI, Kim SC, Chung YH, Lee YS, Min PC : Major complications after orthotopic liver transplantations. Journal of Korean Surgical Society vol.53 no.3 pp.415-431. 1997

14. Lee SG, Lee YJ, Park KM, Jeon H, Choi KM, Kim MH, Lee SG, Sung KB, Hwang S, Cho YP, Woo DH, Kim WY, Min PC: Fifty major liver resections for Klatskin tumor. Korean Journal of Gastroenterology vol.30 no.3 pp.369-378. 1997

15. Lee YJ, Lee SG, Park KM, Jeon H, Nam CW, Hwang S, Min PC: Changing patterns in the serum amylase level and the serum lipase level following hepatic resection with Pringle’s maneuver. Journal of Korean Surgical Society vol.53 no.5 pp.714-719. 1997

16. Hwang S, Lee SG, Park KM, Jeon H, Nam CW, Hwang S, Min PC: Significance of preoperative portal vein embolization of cirrhotic livers for major hepatectomy. Journal of Korean Surgical Society vol.53 no.5 pp.560-570. 1997

17. Kim WY, Lee SG, Lee YJ, Park KM, Jeon H, Hwang S: Clinical experiences of hepatic resection for a ruptured hepatocellular carcinoma. Journal of Korean Surgical Society vol.53 no.6 pp.395-401. 1997

18. Lee HK, Park KM, Jeon H, Lee YJ, Hwang S, Lee SG: The outcomes of curative surgery for primary duodenal malignancy. Journal of Korean Surgical Society vol.54 no.4 pp.531-535. 1997

19. Kim KM, Lee SG, Lee YJ, Park KM, Kim SC, Jeon H, Yoo ES, Ko KS, Han SH, Lee MG, Choi KT, Ko JK, Moon HN: Living related donor liver transplantation in children: Indication and clinical outcome. Journal of Korean Pediatric Society vol.41 no.5 pp.622-632. 1998

20. Lee SG, Lee YJ, Park KM, Jeon H, Hwang S, Lee KH, Lee RK, Lee JJ, Jung JH, Choi WY, Choi JW, Ahn CS, Ha TY, Jung HJ, Lee BC, Ko KH, Park SH, Choi KT, Lee YS, Chung YH, Suh DJ, Kim MH, Lee MH, Sung KB, Kim MK, Ha HS, PC Min : Adult-to-adult living donor liver transplantation. Journal of Korean Surgical Society vol.55 no.5 pp.719-725. 1998

21. Song TJ, Jeon H, Yun JS, Choi SY: Splenic metastasis of lung cancer. Journal of Korean Surgical Society vol.55 no.5 pp.775-778. 1998

22. Youm W, Yun IJ, Jeon H, Lee SY, Jung YS, Lim H, Moon C: Cavoatrial shunt for IVC obstruction by organized thrombosis. Korean Journal of Vascular Surgery vol.15 no.1 pp.153-158. 1999

23. Lee SG, Hwang S, Park KM, Jeon H, Min PC : Regeneration of graft liver in adult-to-adult living donor liver transplantation using a left lobe graft. Journal of Korean Medical Science. vol.13 no.4 pp.350-354. 1998

24. Jeon H, Lee SG, Lee YJ, Park KM, Hwang S, Kim PN, Min PC: Xanthogranulomatous cholecystitis. Korean Journal of HBP Surgery vol.3 no.2 pp.171-177. 1999

/30 3/1/17


25. Shim CS, Moon JH, Cho YD, Lee MS, Jeon H, Jin SY, Lee HK: Neuroendocrine Carcinoma of the ampulla of Vater. Gastrointestinal Endoscopy vol. 51 no.5 pp. 593-594. 2000

26. Shim CS, Moon JH, Cho YD, Hong SJ, Kim JO, Cho JY, Lee MS, Jeon H, Hur KY, Jin SY: Argon plasma coagulation for the endoscopic treatment of a non-resectable Klatskin tumor: In vitro and in vivo study. Digestive Endoscopy. Vol. 12 no.2 pp. 141-146. 2000

27. Jeon H, Ortiz JA, Manzarbeitia CY, Alvarez SC, Sutherland DER, Reich DJ: Combined liver and pancreas procurement from a controlled non-heart-beating donor with aberrant hepatic arterial anatomy. Transplantation vol. 74 no. 11 pp.1636-1638. 2002

28. Yoshizumi T, Gondolesi GE, Bodian CA, Jeon H, Schwartz ME, Fishbein TM, Miller CM, Emre S: A simple new formula to assess liver weight. Transplantation Proceedings. Vol. 35 no. 4 pp.1415-1420. 2003

29. Briceno PJ, Ortiz JA, Manzarbeitia CY, Jeon H, Munoz SJ, Rothstein KD, Araya VR, Gala I, Reich DJ : Liver transplantation using an organ donor With HELLP Syndrome. Transplantation vol. 77. No.1 pp. 137-139. 2004

30. Manzarbeitia CY, Ortiz JA, Jeon H, Munoz SJ, Rothstein KD, Araya VR, Reich DJ : Long-term outcome of controlled, non-heart-beating donor liver transplantation. Transplantation. Vol. 78 no 2. pp. 211-215. 2004

31. Johnston TD, Thacker LR, Jeon H, Lucas B, Ranjan D : Sensitivity of expanded-criteria donor kidneys to cold ischemia time. Clin Transplantation. Vol. 18:S12:28-32. 2004

32. Lopez NM, Jeon H, Ranjan D, Johnston TD: Atypical etiology of massive gastrointestinal bleeding: arterio-enteric fistula following enteric drained pancreas transplant. Am Surg vol.;70. no.6 :529-32. 2004

33. Ranjan D, Chen C, Johnston TD, Jeon H, Nagabhushan M: Curcumin inhibits mitogen stimulated lymphocyte proliferation, NF kappaB activation, and IL-2 signaling. J Surg Res. Vol. 121 no.2 pp.171-177.2004

34. Ranjan D, Chen C, Johnston TD, Jeon H, Ibrahim, M, Drake J, Butterfield DA : Stimulation of Epstein-Barr virus- infected human B cell growth by physiological concentrations of 4-hydroxynonenal. Cell Biochem Funt vol. 24 no.2 pp.147-152 2005

35. Jeon H, Johnston TD, Strup SE, Ibrahim M, Ranjan D: University of Kentucky experience of laparoscopic live donor nephrectomy using two different techniques. Int Surg vol.91 no.6 pp.332-335 2006

36. Ranjan D, Schmonsky K, Johnston TD Jeon H, Bouneva I, Erway E. Financial analysis of potential donor management at a Medicare approved transplant Hospital. Am J Transplant vol. 6 no.1.pp.199-204 2006

37. Sha SH, Johnston, TD, Jeon H, Ranjan D: Effect of Chronic Glucocorticoid Therapy and the Gender Difference on Bone Mineral Density in Liver Transplant Patients. J Surg Res vol135 no.2.pp. 238-241 2006

38. McConathy K, Turner V, Johnston T, Jeon H, Bouneva I, Koch A, Clifford T, Ranjan D. Analysis of smoking patients referred for liver transplantation and its adverse impact of short-term outcomes. J Ky Med Assoc Jun: 105(6):261-6 2007

39. Clifford T, Johnston T, Jeon H, Gedaly R, Ranjan D. A Pharmacoeconomic analysis of liver transplant charges. Progress in Transplantation, Vol 17, No. 4, December 2007

40. Jeon H, McHugh P, Banerjee A, Gedaly R, Johnston T, Ranjan D. The use of Dacron graft for cavo-cavostomy in Orthotopic Liver Transplantation. Transplantation 2008 vol. 85 no. 4:651-653

41. Gedaly G, Jeon H, Johnston T, McHugh P, Rowland R, Ranjan D. Surgical treatment of a rare primary renal carcinoid tumor with liver metastasis. World Journal of Surgical Oncology 2008, vol. 6 no. 41

/30 3/1/17


42. Jeon H, McHugh P, Gedaly R, Johnston T, Ranjan D, Pu L. Successful Management of Eviscerated Renal Allograft with Preservation of Function. Am J Trans 2008 vol. 8 no.5:1067-70

43. Johnston T, Jeon H, Gedaly R, Ranjan R. Importance of local infection in hepatic artery pseudoaneurysms. Liver Transplantation 2008. vol. 14 no. 3:388

44. Gedaly R, Clifford, TM, McHugh PP, Jeon H, Johnston, TD, Ranjan D. Prevalent immunosuppressive strategies in liver transplantation for hepatitis C: results of multi-center international survey. Transplant Int. 2008. May 21

45. Chen C, Johnston TD, Jeon H, Gedaly R, McHugh P, Ranjan D. Cyclosporin A up-regulates and activates protein kinase C-zeta in EBV-infected and EBV-transformed human B-cells. J Surg Res. 2008 Apr 8.

46. Jeon H, Ranjan D. The easiest way to improve the outcome of suboptimal liver graft. Liver Transplantation 2008 Jun;14(6):905; author reply 906-7

47. McHugh P, Jeon H, Gedaly R, Johnston T, DePriest P, Ranjan D. Vaginal Varices with Massive Hemorrhage in a Patient with NASH and Portal Hypertension: Successful Treatment with Liver Transplantation. Liver Transplantation 2008 Oct; 14(10):1538-40.

48. Chen C, Jeon H, Johnston, TD, Gedaly R, McHugh PP, Ranjan D. Cyclosporin A-induced lipid and protein oxidation in human B-cells and in Epstein-Barr virus-infected B-cells is prevented by antioxidants. J Invest Surg. 2008 Jul-Aug; 21(4):201-8.

49. Gedaly R, McHugh PP, Johnston TD, Jeon H, Koch A, Clifford TM, Ranjan D. Predictors of relapse to alcohol and illicit drugs after liver transplantation for alcoholic liver disease. Transplantation. 2008 Oct 27; 86(8):1090-5.

50. Chen C, Johnston TD, Jeon H, Gedaly, R, McHugh PP, Burke TG, Ranjan D. An in vitro study of liposomal curcumin: Stability, toxicity and biological activity in human lymphocytes and Epstein-Barr virus-transformed human B-cells. Int J Pharm. 2008 Sep 17.

51. McHugh PP, Johnston TD, Gedaly R, Jeon H, Ranjan D. Seatbelt injury resulting in functional loss of a transplanted kidney. Prog Transplant. 2008 Sep;18(3):199-202.

52. McHugh PP, Johnston TD, Gedaly R, Jeon H, Ranjan D. Successful open pulmonary embolectomy for acute massive pulmonary embolism in a recent kidney transplant recipient. Ann Transplant. 2008 13(3): 19-22

53. Giulianotti P, Gorodner V, Sbrana F, Tzvetanov I, Jeon H, Bianco F, Kinzer K, Oberholzer J, Benedetti E. Robotic transabdominal kidney transplantation in a morbidly obese patient. Am J Transplant. 2010 10(6): 1478 – 1482

54. Jeon H, Lee SG. Living donor liver transplantation. Curr Opin Organ Transplant. 2010 15(3): 283 – 287 Review.

55. Krishnamoorthy V, Li J, Jeon H, Nicolau R. Use of an Inferior Epigastic Arterial Catheter in a Patient With Difficult Vascular Access. J Cardiothorac Vasc Anesth 2011 Jun 1. [Epub ahead of print]

56. Ghafari JL, Bhati C, John E, Tzvetanov IG, Testa G, Jeon H, Oberholzer J, Benedetti E. Long-term follow-up in adult living donors for combined liver/bowel transplant in pediatric recipients: A single center experience. Pediatr Transplant. 2011 Jun;15(4):425-9.

57. Tzvetanov IG, Bhati CS, Jeon H, Glover AE, Oberholzer J, Benedetti E. Segmental intestinal autotransplantation after extensive enterectomy for removal of large intra-abdominal desmoid tumors of the mesentery root: Initial experience. Surgery. 2011 Oct 5.

/30 3/1/17


58. Jeon H, Bhati C, Tzvetanov I, Oberholzer J, Kinzer K, Benedetti E. Calibrated extra-anatomic hepatic arterial reconstruction in living donor liver transplantation. Transpl Int. 2012 Jan; 25(1):e16-8.

59. Giulianotti P, Gorodner V, Sbrana F, Tzvetanov I, Jeon H, Bianco F, Kinzer K, Oberholzer J, Benedetti E. Robotic transabdominal kidney transplantation in a morbidly obese patient. Am J Transplant. 2010 Jun; 10(6):1478-82. Epub 2010 May 10.

60. Ghafari J, Tzvetanov I, Spaggiari M, Jeon H, Oberholzer J, Benedetti E. The effect of small bowel living donation on donor lipid profile. Transpl Int. 2012 Jan;25(1):e19-20. Epub 2011 Oct 11.

61. Giulianotti PC, Tzvetanov I, Jeon H, Bianco F, Spaggiari M, Oberholzer J, Benedetti E. Robot-assisted right lobe donor hepatectomy. Transpl Int. 2012 Jan; 25(1):e5-9. doi: 10.1111/j.1432-2277.2011.01373.x. Epub 2011 Oct 27.

62. Sohn AJ, Jeon H, Ahn J. Primary care of the liver transplant recipient. Prim Care. 2011 Sep; 38(3):499-514; ix. Review.

63. Tzvetanov I, Spaggiari M, Oberholzer J, Setty S, Stephenson A, Thielke J, West-Thielke P, Jeon H, Danielson KK, Kaplan B, Benedetti E. Cell population in Spleens during antibody-mediated rejection: pathologic and clinical findings. Transplantation. 2012 Aug 15; 94(3): 255-62. PubMed PMID: 22790386.

64. Tzvetanov I, Spaggiari M, Jeon H, Bhati C, Hassan S, Joseph J, Heinrich L, Thielke J, Setty S, Oberholzer J, Benedetti E. Rescue Splenectomy in a Case of Humoral Rejection in ABO-Incompatible Simultaneous Liver-Kidney Transplantation. Transplantation. 2012 Jan 27; 93(2):e1-2.

65. Tzvetanov I, Spaggiari M, Jeon H, Roca RG, Bhati C, Oberholzer J, Benedetti E. The role of splenectomy in the setting of refractory humoral rejection after kidney transplantation. Transplant Proc. 2012 Jun; 44(5):1254-8. PubMed PMID: 22663995.

66. Wang Y, Mendoza-Elias JE, Qi M, Harvat TA, Ahn SJ, Lee D, Gutierrez D, Jeon H, Paushter D, Oberholzer J. Implication of mitochondrial cytoprotection in human islet isolation and transplantation. Biochem Res Int. 2012; 2012:395974. Epub 2012 May 7. PubMed PMID: 22611495: PubMed Central PMCID: PMC3352213.

67. Lo JF, Wang Y, Blake A, Yu G, Harvat TA, Jeon H, Oberholzer J, Eddington DT. Islet precondition via multimodal microfluidic modulation of intermittent hypoxia. Anal Chem. 2012 Feb 21; 84(4):1987-93. Epub 2012 Feb1. PubMed PMID: 22296179; PubMed Central PMCID: PMC3302975.

68. Wang Y, Lee D, Zhang L, Jeon H, Mendoza-Elias JE, Harvat TA, Hassan SZ, Zhou A, Eddington DT, Oberholzer J. Systematic prevention of bubble formation and accumulation for long-term culture of pancreatic islet cells in microfluidic device. Biomed Microdevices. 2012 Apr; 14(2):419-26.

69. Tzvetanov I, Spaggiari M, Joseph J, Jeon H, Thielke J, Oberholzer J, Benedetti E. The use of bortezomib as a rescue treatment for acute antibody-mediated rejection: report of three cases and review of literature. Transplant Proc. 2012 Dec; 44(10):2971-5

70. Tzvetanov I, Spaggiari M, Jeon H, Garcia-Roca R, Osipova M, Oberholzer J, Benedetti E. Renal artery aneurysm in robotic donor nephrectomy: a case report. Exp Clin Transplant. 2012 Jun; 10(3):293-5. Erratum in: Exp Clin Transplant. 2012 Aug; 10(4):418.

71. Darwish Murad S, Kim WR, Harnois DM, Douglas DD, Burton J, Kulik LM, Botha JF, Mezrich JD, Chapman WC, Schwartz JJ, Hong JC, Emond JC, Jeon H, Rosen CB, Gores GJ, Heimbach JK. Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers. Gastroenterology. 2012 Jul;143(1):88-98.e3

/30 3/1/17


72. Yerlioglu E, Krishnamoorthy V, Jeon H, Gustin A, Nicolau-Raducu R. Patentforamen ovale and intracardiac thrombus identified by transesophagealechocardiography during liver transplantation. J Cardiothorac Vasc Anesth. 2012Dec; 26(6):1069-73

73. Casadaban L, Parvinian A, Tzvetanov IG, Jeon H, Oberholzer J, Benedetti E, Bui JT, Gaba RC. Unconventional Extrahepatic Neovascularization After Transplant Hepatic Artery Thrombosis: A Case Report. Transplant Proc. 2013 Jul 29. doi:pii: S0041-1345(13)

74. Oberholzer J, Giulianotti P, Danielson KK, Spaggiari M, Bejarano-Pineda L, Bianco F, Tzvetanov I, Ayloo S, Jeon H, Garcia-Roca R, Thielke J, Tang I, Akkina S, Becker B, Kinzer K, Patel A, Benedetti E. Minimally invasive robotic kidney transplantation for obese patients previously denied access to transplantation. Am J Transplant. 2013 Mar; 13(3):721-8.

75. Choudhury N, Khan AB, Tzvetanov I, Garcia-Roca R, Oberholzer J, Benedetti E, Jeon H. Cerebellar abscess caused by Listeria monocytogenes in a liver transplant patient. Transpl Infect Dis. 2013 Dec;15(6):E224-8.

76. Tzvetanov I, Giulianotti PC, Bejarano-Pineda L, Jeon H, Garcia-Roca R, Bianco F, Oberholzer J, Benedetti E. Robotic-assisted kidney transplantation. Surg Clin North Am. 2013 Dec;93(6):1309-23

77. Tzvetanov I, Bejarano-Pineda L, Giulianotti PC, Jeon H, Garcia-Roca R, Bianco F, Oberholzer J, Benedetti E. State of the art of robotic surgery in organ transplantation. World J Surg. 2013 Dec;37(12):2791-9.

78. Choudhury N, Khan AB, Tzvetanov I, Garcia-Roca R, Oberholzer J, Benedetti E, Jeon H. Multiple Aspergillus Brain Abscesses after Liver Transplantation. Transplantation 2014 Jun 27;97(12):e72-e73

79. Tzvetanov I, D'Amico G, Walczak D, Jeon H, Garcia-Roca R, Oberholzer J, Benedetti E. High Rate of Unemployment After Kidney Transplantation: Analysis of the United Network for Organ Sharing Database. Transplant Proc. 2014 May 14. pii: S0041-1345(14)00121-32014 May 14. pii: S0041-1345(14)00121-3

80. Khan A, Park P, Oberholzer J, Tzvetanov I, Garcia Roca R, Gaba RC, Benedetti E, Jeon H. Concurrent hepatic artery and portal vein thrombosis after orthotopic liver transplantation with preserved allografts. Case Rep Transplant. 2014;2014:384295.

81. Naffouje SA, Tzvetanov, I, Bui JT, Gaba R, Bernardo K, Jeon H. Obesity increases the risk of primary nonfunction and early access loss, and decreases overall patency in patients who underwent Hemodialysis Reliable Outflow device placement. Ann Vasc Surg. 2016 Oct;36:236-243

82. Garcia-Roca R, Garcia-Aroz S, Tzvetanov I, Jeon H, Oberholzer J, Benedetti E. Single center experience with robotic kidney transplantation for recipients with BMI of 40kg/m2 or greater: A comparison with the UNOS registry. Transplantation. 2017 Jan;101(1):191-196.

83. Garcia-Roca R, Tzvetanov IG, Jeon H, Hetterman E, Oberholzer J, Benedetti E. Successful living donor intestinal transplantation in cross-match positive recipients: Initial experience. World J Gastrointest Surg. 2016 Jan 27;8(1):101-105

BOOK CHAPTERS AND MONOGRAPHS

/30 3/1/17


1. Reich DJ, Jeon H, Manzarbeitia CY : Complications in Hepatobiliary Surgery, in Complications in General Surgery, Nadey Hakim, Editor, Imperial Press, London, March 2007, ISBN-13: 978-1860946929

2. Jeon H, Ranjan D : Liver transplantation for hepatocellular carcinoma under MELD score-bases allocation system, in Liver Transplantation and Hepatocellolar Carcinoma, Cataldo Doria, Editor, International College of Surgeons, Chicago, November 2007

3. Jeon H, Ramaiah C, Ranjan D : Venous and lymphatic disorders in transplantation, in Venous and Lymphatic Diseases, Robert S. Dieter, editor, McGraw Hill, New York, January 2011, ISBN : 978-0-07-160158-9

4. Jeon H, Shin TH, Tzvetanov I, Benedetti E : Minimally invasive live donor hepatectomy, in Contemporary Liver Transplantation, Cataldo Doria, editor, Springer International Publishing Switzerland, February 2015, ISBN: 978-3-319-05543-5

5. Shin TH, Jeon H : Surgical treatment of cholangiocarcinoma, in Cholangiocarcinoma, Charles E. Ray et al. , editors, Nova Science Publishers, Inc., New York, 2015, ISBN: 978-162948-034-3

/30 3/1/17


PRESENTATIONS Presented Abstracts at Regional, National, and International Meetings

1. Lee YJ, Lee SG, Park KM, Jeon H, Hwang S, Min PC: A case report of localized sclerosing cholangitis in common hepatic duct. Asian Society of Hepatobiliary and Pancreatic Surgery, Tokyo, Japan, June 1997

2. Lee YJ, Lee SG, Park KM, Jeon H, Hwang S, Min PC: Hepatopancreatoduodenectomy for the advanced biliary carcinomas. Asian Society of Hepatobiliary and Pancreatic Surgery, Tokyo, Japan, June 1997

3. Jeon H, Hwang S, Park KM, Lee YJ, Lee SG: Pancreatoduodenectomy or total pancreatectomy combined with vascular or adjacent organ resection in periampullary malignancy. Asian Society of Hepatobiliary and Pancreatic Surgery, Tokyo, Japan, June 1997

4. Lee YJ, Lee SG, Park KM, Jeon H, Hwang S, Min PC: Report of 2 cases of advanced mucin-secreting pancreatic tumor. Asian Society of Hepatobiliary and Pancreatic Surgery, Tokyo, Japan, June 1997

5. Jeon H, Nam CW, Park KM, Lee YJ, Lee SG, Min PC: Safety of Major hepatobiliary and pancreatic surgery in the elderly. Asian Society of Hepatobiliary and Pancreatic Surgery, Tokyo, Japan 1997

6. Jeon H, Park KM, Lee YJ, Lee SG, Min PC: Single layer parachuted intussussepted pancreaticojejunostomy. Asian Society of Hepatobiliary and Pancreatic Surgery, Tokyo, Japan, June 1997

7. Yun IJ, Jeon H, Cho KS, Won KS, Ryu KW, Lee HS, Kim YB, Kim YI, Park RK, Lee DH: A case of methyl malonic academia treated with living related liver transplantation. International Congress of the Transplantation Society, Rome, Italy, September 2000

8. Yoshizumi T, Gondolesi GE, Jeon H, Schwartz ME, Shimada M, Miller CM, Emre S: An assessment of standard liver volume, description of a new formula. American Transplant Congress, Washington D.C., April 2002

9. Jeon H, Reich DJ, Kaul V, Braitman L, Nathan HM, Hasz RD, Ortiz JA, Araya VR, Rothstein KD, Munoz SJ, Manzarbeitia CY: Livers from morbidly obese donors: Results of 97 attempted procurement-Half provided transplants. International Liver Transplantation Society, Chicago, June 2002

10. Manzarbeitia CY, Reich DJ, Ortiz JA, Munoz SJ, Araya VR, Rothstein KD, Jeon H, Alvarez SC, Oleaga J, Horrow M : Non-surgical management of late hepatic artery stenosis after liver transplantation. International Liver Transplantation Society, Chicago, June 2002

11. Jeon H, Ortiz JA, Giraldo JC, Reich DJ, Manzarbeitia CY: Risk of deep vein thrombosis associated with venovenous bypass for liver transplantation. International Liver Transplantation Society, Chicago, June 2002

12. Ranjan D, Johston TD, Jeon H, Rogers C, Blair F: Comparative financial analysis of liver transplantation in the pre and post MELD era. American Transplant Congress, Washington D.C., June 2004

13. Ranjan D, Chen C, Jeon H, Johston TD: Curcumin inhibit mixed lymphocyte reaction stiulated cell proliferation via inhibition of IL-2. American Transplant Congress, Washington D.C., June 2004

14. Cox M, Grantz D, Polly L, Jeon H, Ibrahim M, Johston TD, Ranjan D, “Effects of an Internal Task Force Fiscal Evaluation of a Liver Transplant Program” Presented at: UNOS Meeting Miami, Florida, May 2004

/30 3/1/17


15. Mozafarri F, Jeon H, Ibrahim M, Johston TD, Ranjan D. “Hepactic Artery Thrombosis after Adult Orthotopic Liver Transplantation: Spectrum of Complications.” Presented at: ICA Meeting 2004 Lexington, Kentucky, July 2004

16. Jeon H, Johston TD, Strup SE, Ibrahim M, Ranjan D : University of Kentucky experience of laparoscopic live donor nephrectomy using two different techniques.Presented at Annual Congress of International College of Surgeons. July 2004 Anchorage, Alaska

17. Bouneva I, Johston TD, Turner V, Schmonsky K, Jeon H, Ibrahim M, Ranjan D: Clinical and financial impact of obesity in liver transplantation in a rural area. American Association of Study of Liver Disease, Boston, October 2004

18. Schmonsky K, Turner V, Bouneva I, Ibrahim M, Jeon H, Johston TD, Ranjan D: Analysis of smoking in patients referred for liver transplantation and its adverse impact on short term outcomes. American Association of Study of Liver Disease, Boston, October 2004 Awarded Presentation

19. Bouneva I, Johston TD, Jeon H, Turner V, Ranjan D: “Clinical predictors of greater resource utilization in orthotopic liver transplantation”. Presented at: ATC Meeting, Seattle, Washington (May 2005)

20. Schmonsky K, Turner V, Bouneva I, Johston TD, Jeon H, Ibrahim M, and Ranjan D. "Financial Management of Potential Donor Management at a Medicare Approved Transplant Hospital." Presented at: American Transplant Congress, Seattle Washington (May 2005).

21. Bouneva I, Johnston TD, Jeon H, Turner V, Ranjan D. “Clinical predictors of greater resource utilization in orthotopic liver transplantation”. Presented at: Transplant Administrators Meeting Memphis, Tennessee (May 2005)

22. Schmonsky K., Turner V., Bouneva I., Johnston T., Jeon H., Ibrahim M., and Ranjan D. "Financial Management of Potential Donor Management at a Medicare Approved Transplant Hospital." Presented at: American Transplant Congress, Seattle Washington (May 2005).

23. Schmonsky K., Turner V., Bouneva I., Johnston T., Jeon H., Ibrahim M., and Ranjan D. "Financial Management of Potential Donor Management at a Medicare Approved Transplant Hospital." Presented at: Transplant Administrators Meeting Memphis, Tennessee (May 2005)

24. Kaur PJ, Johnston T., Jeon H., Ranjan D. “Whipple Pancreato-duodenectomy for arteriovenous malformation and gastrointestinal bleeding”. Presented at: AAS. San Diego, CA (2006)

25. Chen C., Johnston T., Jeon H, Shah S., Ranjan D. “CsA induced MDA formation in EBV infected and uninfected human B cells”. Presented at: Academic Surgical Congress. San Diego, CA (2006)

26. Chen C., Johnston T., Jeon H, Ranjan D. “CsA activates NFkB in EBV infected and uninfected human B cells”. Presented at: Academic Surgical Congress. San Diego, CA (2006)

27. Shah S., Johnston T., Jeon H, Ranjan D. “Effect of Chronic Glucocorticoid Therapy and the Gender Difference on Bone Transplant Patients”. Presented at: Academic Surgical Congress. San Diego, CA (2006)

28. Mozaferri F., Jeon H, Johnston T., Ranjan D. “Dacron Graft for Vena Cava Replacement during Liver Transplantation.” Presented at: Academic Surgical Congress. San Diego, CA (2006)

/30 3/1/17


29. Clifford T, Johnston T, Jeon H, Ranjan D. “A Pharmacoeconomic Analysis of Liver Transplant Charges at a Single Institution Over 11 Years.” Presented at: UNOS Transplant Management Forum. San Francisco, CA (2006)

30. Johnston T,. Jeon H, Gedaly R, Ranjan D. A Meta-Analysis of the Impact of Multiple arteries in Allografts Procured by Laparoscopic Nephrectomy, Presented at the American Society of Nephrology Meeting in San Diego, (Nov 2006).

31. Johnston T, Gedaly R, Jeon H, Ranjan D. Are multiple arteries a contraindication for living donor kidney transplant? Presented at the American Transplant Society Meeting Held in Marco Island, Florida, (January 2007).

32. Johnston T, Gedaly R, Jeon H, Ranjan D. Obesity and Renal Transplant graft Survival: A Meta-Analysis. Presented at the Association of Academic Surgeons, Phoenix, AZ , (February 2007).

33. Johnston T, Gedaly R, Jeon H, Ranjan D. The risk of graft failure in laparoscopically procured kidneys having multiple renal arteries in less than the risk with deceased donor kidneys. Presented at the Association of Academic Surgeons, Phoenix, AZ , (February 2007)

34. Ranjan D, Johnston TD, Jeon H, Gedaly R. Liver transplant subsequent care revenue: impact of Critical Care. ICS. Reno, NV (June 2007)

35. Johnston T, Gedaly R, Jeon H, Ranjan D. Outcomes with Non-Heart Beating Liver Donors: A Meta-Analysis. University of Kentucky, Transplant Division. Presented at the European Society of Organ Transplantation in Prague, Czech Republic (September 2007).

36. Gedaly R, Gilbert J, Jeon H, Koch A, Ranjan D. Predictors of Survival in Patients with Hepatocellular Carcinoma after Transplantation. University of Kentucky, Transplant Division. Presented at the European Society of Organ Transplantation in Prague, Czech Republic (September 2007).

37. Johnston T, Gedaly R, Jeon H, Ranjan D. Impact of Obesity in Liver Transplant Outcomes: Not a Simple Answer. University of Kentucky, Transplant Division. ASTS winter Symposium, Marco Island FL, (January 2008).

38. Jeon H, McHugh PP, Johnston TD, Gedaly R, Ranjan D. Management of hepatic artery pseudoaneurysm after liver transplantation. IHPBA Mumbai, India, (March 2008)

39. Jeon H, McHugh PP, Johnston TD, Gedaly R, Ranjan D. Comparison of pancreas transplantation outcome by drainage type. IHPBA Mumbai, India, (March 2008)

40. Jeon H, McHugh PP, Clifford TM, Johnston TD, Gedaly R, Ranjan D. Basiliximab induction in orthotopic liver transplant recipients for delayed tacrolimus initiation and renal protection. IHPBA Mumbai, India, (March 2008)

41. Gedaly R, Gilbert J, Johnston TD, Jeon H, Shokouh-Amiri H, Vera S Koch A, Ranjan D. Tumor size ; The best and most powerful surrogate of vascular invasion. ILTS Paris, France, (July 2008)

42. Bhati C, Tzvetanov I, Oberholzer J, Benedetti E, Jeon H ; Standard liver volume in morbidly obese individuals without medical illness. American Transplant Congress. San Diego, (May 2010)

43. Campara M, Jeon H, Tzvetanov I, Oberholzer J, Benedetti E, Tang I ; Renal allograft outcome in combined liver-kidney transplant on calcineurin inhibitor vs. CNI and mycophenolate maintenance immunesuppression. American Transplant Congress. San Diego, (May 2010)

/30 3/1/17


44. Giulianotti PC, Oberholzer J, Tzvetanov I, Jeon H, Bhati C, Benedetti E ; Fully robotic kidney transplantation in morbidly obese recipients: Initial experience. American Transplant Congress. San Diego, (May 2010)

45. Tzvetanov I, Oberholzer J, Jeon H, Kinzer K, Benedetti E. “Robot-Assisted Live Donor Nephrectomies at the University of Illinois at Chicago” Oral Presentation, Clinical Robotic Surgical Association, 2nd Worldwide Congress, Chicago, IL, (September 2010).

46. Kinzer K, Tzvetanov I, Jeon H, Gorodner V, Galvani C, Horgan S, Benedetti E, Oberholzer J ; Robotic assisted live donor nephrectomy : Ten year institutional report and analysis. American Transplant Congress. Philadelphia, (May 2011)

47. Tzvetanov I, Spaggiari M, Jeon H, Garcia-Roca R, Campara M, Thielke J, Oberholzer J, Benedetti E : Simultaneous ABO Incompatibility and Positive Cross-Match in Kidney Transplantation: Our Experience and Review of Literature. American Transplant Congress, Boston, MA. (June 2012). Awarded Presentation

48. Tzvetanov I, Oberholzer J, Spaggiari M, Jeon H, Garcia-Roca R, Campara M, Thielke J, Giulianotti PC, Benedetti E : Robotic Kidney Transplantation in Obese Recipients: Preliminary Experience. American Transplant Congress, Boston, MA. (June 2012). Oral Presentation

49. Spaggiari M, Tzvetanov I, Setty S, Jeon H, Garcia-Roca R, Oberholzer J, Benedetti E : Spleen Cell Populations Involved in Antibody Mediated Rejection after Kidney Transplantation: Pathological and Clinical Findings. American Transplant Congress, Boston, MA. (June 2012).

50. Bhati C, Parikh K, Danielson K, Tzvetanov I, Oberholzer J, Benedetti E, Jeon H : Estimated Measurement of Standard Liver Volume in Highly Obese Individuals without Medical Illness. American Transplant Congress, Boston, MA. (June 2012).

51. Garcia-Roca R, Choudhury N, Tzvetanov I, Jeon H, Oberholzer J, Benedetti E Understanding Racial Disparity in Living Donor Kidney Transplantation. American Transplant Congress, Boston, MA. (June 2012).

52. Tzvetanov I, Bejarano-Pineda L, Setty S, Harbhajanka A, Khan A, Jeon H, Garcia-Roca R, Oberholzer J, Benedetti E. The Association of B Cell Population in Splenic Histology of ABO Incompatible Kidney Transplantation and One-Year Graft and Recipient Survival. American Transplant Congress, Seattle, WA, (May 2013).

53. Bhati C, Khan A, Garcia-Roca R, Tzvetanov I, Oberholzer J, Benedetti , Jeon H: Liver Transplantation in Patients Older Than 70 Years: Call of Caution. World Transplant Congress, San Francisco, CA (July 2014).

54. Jeon H, Hyoung H., Park P, Khan A, Bhati C, Tzvetanov I, Garcia-Roca R, Oberholzer J, Benedetti E: A Single U.S. Center Experience of Orthotopic Liver Transplantation in Patients With MELD Score Greater than 35. World Transplant Congress, San Francisco, CA (July 2014).

55. Khan A, Hughes D, Bhatti C, Tzvetanov I, Garcia-Roca R, Akkina S, Oberholzer J, Benedetti E, Jeon H: A Single-Center, Retrospective Evaluation of Outcomes Following Cross Match Positive Simultaneous Liver Kidney Transplantation. World Transplant Congress, San Francisco, CA (July 2014).

56. Tzvetanov I, D’Amico G, Giulianotti P.C., Jeon H Garcia-Roca R, Oberholzer J, Benedetti E: Superior Two-year Graft Survival After Robotic Kidney Transplantation in Obese Recipients: Does Wound Infection Really Matter? World Transplant Congress, San Francisco. CA (July 2014).

/30 3/1/17


57. Garcia-Roca R, Williams T, D’Amico G, Tzvetanov I, Jeon H, Giulianotti P.C., Bianco F, Oberholzer J, Benedetti E: Robotic Kidney Transplant in Morbid Obesity. World Transplant Congress, San Francisco, CA (July 2014)

58. Garcia-Roca R, D’Amico G, Williams T, Tzvetanov I, Jeon H, Giulianotti P.C., Bianco F, Oberholzer J, Benedetti E: One Hundred-four Robotic Kidney Transplant. World Transplant Congress, San Francisco, CA (July 2014)

59. Tzvetanov I, D’Amico G, Walczak D, Jeon H, Garcia-Roca R, Oberholzer J, Benedetti E:high Rate of Unemployment After Kidney Transplantation: Analysis of the UNOS Database. World Transplant Congress, San Francisco, CA (July 2014)

60. Campara M, Tzvetanov I, Giulianotti P.C., Khan A, Garcia-Roca R, Jeon H, Holterman M, John E, Benedetti E: Living Donor Parathyroid Allotransplantation. World Transplant Congress, San Francisco, CA (July 2014)

61. Han H, Khan A, Park P, Bhati C, Tzvetanov I, Garcia-Roca R, Oberholzer J, Benedetti E, Jeon H: Single center retrospective evaluation of the survival differences as per discharge disposition of OLT patients with high MELD score. World Transplant Congress, San Francisco, CA (July 2014)

62. Tzvetanov I, D'Amico G, Georgiev G, Jeon H, Garcia-Roca R, Benedetti E, Oberholzer J. Combined Robotic Kidney Transplantation and Sleeve Gastrectomy in Obese Recipients: Initial Results from Prospective Randomized Study. American Transplant Congress, Philadelphia, PA (May 2015)

63. Tzvetanov I, D'AmicoG, Georgiev G, Giulianotti P, Jeon H, Garcia-Roca R, Oberholzer J, Benedetti E. Robotic Kidney Transplantation in Obese Recipients Can Lead to Superior Outcomes in Terms of Wound Infection and Graft Survival. American Transplant Congress, Philadelphia, PA (May 2015)

64. Garcia Roca R, Martinez Parra C, Tzvetanov I, Jeon H, Benedetti E, Oberholzer J. Application of the Clavien Classification of Surgical Complications to Robotic Kidney Transplantation. American Transplant Congress, Philadelphia, PA (May 2015)

65. Bhati C, Tzvetanov I, Garcia-Roca R, Oberholzer J, Benedetti E, Jeon H. U.S. National Experience of Liver Transplantation Using Allografts from Octogenarian Donors. American Transplant Congress, Philadelphia, PA (May 2015)

INVITED LECTURESHIPS 10.22.2014 Transplant Symposium: Mininally invasive donor hepatectomy.

Medical College of Wisconsin, Milwaukee, WI

04.25.2014 Surgical Grand Round: Recent Advances of Solid Organ Transplantation. Mount Sinai Medical Center, Chicago, IL

03.26.2014 Expanded criteria liver donors other than DCD (Panel Presentation and Discussion) Clinical Congress, International Pancreatohepatobiliary Association (03.22.2014 – 3.27.2014), Seoul, Korea

02.13.2014 Liver transplantation in 2014 Medical Grand Round, Advocate Christ Medical Center, Oak Lawn, IL

/30 3/1/17

http://www.atcmeetingabstracts.com/abstract/u-s-national-experience-of-liver-transplantation-using-allografts-from-octogenarian-donors/






11.17.2012 Liver transplantation in minorities, Bridging the gap symposium, University of Illinois at Chicago, Chicago, IL

11.01.2012 Living kidney donation – What is really like. National Kidney Foundation of Illinois, Chicago, IL

10.05.2012 The Current Status of Living Donor Liver Transplantation in the Far East: Japan, Korea, and Hong Kong. 6th International Conference “Living Donor Abdominal Organ Transplantation: State of the Art”, Bari, Italy

03.12.2012 Living with kidney transplantation. National Kidney Foundation of Illinois, Chicago, IL

11.04.2011 Barriers in renal transplantation. Multidisciplinary Conference, American Kidney Foundation, Oakbrook, IL

10.26.2011 Current management of colorectal liver metastasis Bridging the gap symposium – Emerging Health Issues in Underrepresented Minorities, Chicago, IL

10.13.2011 Surgical Grand Round: Liver transplantation in 2011. Mount Sinai Medical Center, Chicago, IL

09.27.2011 Donation after cardiac death (Panel Presentation and Discussion) Clilnical Congress of Asian Society of Transplantation , Seoul, Korea

05.14.2011 Training and education in clinical transplantation. (Panel Presentation and Discussion) Academic Congress, Korean Medical Association, Seoul, Korea

11.21.2010 Organ Recovery symposium: Logistics and Technique of Multiorgan Recovery. Korean Organ Donation Agency, Seoul, Korea

12.03.2009 Medical Grand Round: Hepatocellular carcinoma. Advocate Christ Medical Center, Chicago, IL

02.21.2008 Transplant Teaching Conference: Living donor liver transplantation between adults – East Asian Experience. Virginia Commonwealth University, Richmond, VA

10.04.2007 7TH Annual CEU Roundtable Conference for Health Care Professionals, Professional Healthcare Institute of America, Louisville, KY

09.11.2007 Kentucky Organ Donor Affiliates Board Meeting: Using extended criteria donors through a successful working relationship between OPO‘s and transplant programs, Lexington, KY

07.27.2007 Surgical Grand Round: Liver Transplantation – Update 2007, College of Medicine, Korea University, Seoul, Korea

/30 3/1/17


07.26.2007 ICU Lecture Series: Management of organ donors. Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Korea

07.20.2007 Visiting Professorship, 1st International Transplant Symposium: Liver transplantation for hepatitis C. Transplant Research Center, Konkuk University, Seoul, Korea

07.18.2007 Surgical Grand Round: Use of marginal donor organs in liver transplantation. College of Medicine, University of Ulsan, Seoul, Korea

08.05.2005 Surgical Grand Round: Liver Transplantation for Hepatocellular Carcinoma. College of Medicine, Seoul National University, Seoul, Korea

03.18.2004

What’s hot and new in solid organ transplantation Korean Bioscientist Association in Lexington, Kentucky

03.24.2000 Surgical Grand Round: Living related liver transplantation. Korea University College of Medicine, Seoul, Korea

05.11.2000 Inaugural Conference of Korean Society of Hereditary Metabolic Disorders: Role of liver transplantation for inborn errors of metabolism. Seoul, Korea

11.07.1999 Transplant Grand Round: Initial experience of living-donor liver transplantation in Korea. Gottingen University, Gottingen, Germany

/30 3/1/17


EDUCATIONAL ACTIVITIES Departmental & Medical School Presentations

University of Illinois at Chicago 05.27.2009 Surgical Grand Round: Partial liver transplantation – Technical

Challenges and their solutions.

2010– 2017 Surgery Resident Teaching Conferences: Transplantation

2010 – 2017

Surgery Resident Teaching Conferences: Hepatic Tumors

07.07.2010 Family Medicine Grand Round: Long-term management after transplantation by a primary care physician.

2011- 2017 Surgery Resident Teaching Conferences: Surgical Anatomy of Liver, Benign hepatic tumor, Transplantation

2011-2017 Gastroenterology Fellow Core Lecture: Liver Transplantation Previous Institutions

2005 - 2008 “Hepatobiliary system” for ABSITE review

Department of Surgery, University of Kentucky

11.16.2006 “Introduction to solid organ transplantation” Ward O. Griffen Surgical Society College of Medicine, University of Kentucky

02.22.2005 Liver Transplant –Update 2005 : “What Radiologists Needs to Know” lecture series: Department of Radiology, College of Medicine, University of Kentucky: Lexington, Kentucky

2005 - 2009 General Surgery Resident Conference: “Liver Surgery”. College of Medicine, University of Kentucky, Lexington, Kentucky

11.10.2004 Surgical GrandRound: Partial liver transplantation – Technical Challenges and their solutions. College of Medicine, University of Kentucky, Lexington, Kentucky

10.16.2002 Use of marginal donor organs for transplantation. Department of Surgery, Albert Einstein Medical Center, Jefferson Medical College, Philadelphia, Pennsylvania

/30 3/1/17


10.30.2001 Medical Grand Round, Living donor liver transplantation. Department of Medicine, Albert Einstein Medical Center, Jefferson Medical College, Philadelphia, Pennsylvania

05.12.1998 Surgical Grand Round: Nutritional support of surgical patient. Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea

Medical School Courses Prepared & Taught University of Illinois at Chicago

Course Co-director: Radiology – Surgery – Anatomy Combined elective: October 2014 – 2016 (An elective course for 4th year medical students for 12 weeks – 4 weeks for each of three groups) Lecturer: Medical Pharmacology: Immune suppressive medications for 2nd year medical students: October 2012 to May 2013. Course Co-director: Transplantation Physiology: September 2010 to 2016 (A part of “Introduction to patient care” program) a ten-week lecture course given as an elective for second year medical students, offered in both fall and spring semesters every year since Fall 2010 to present Preceptor for 2nd year medical students: Essentials of Clinical Medicine: Abdominal examination. May 2009 to 2016. Lecturer and preceptor for 3rd year medical students: General Surgery Core Clerkship: May 2009 to 2016. Acute abdomen, Stress response to trauma and surgery, transplantation, clinical simulation

Course coordinator and preceptor for 4th year medical students: Transplant Surgery Clerkship (Elective): May 2009 to 2016. ELEC 677

History of Modern Surgery: Organ Transplantation: The Honors College: Course Hon 201: October 2009

Previous Institutions “Introduction to Solid Organ Transplantation”, a twelve-week lecture course given as an elective for first and second year medical students at University of Kentucky, offered in both fall and spring semesters every year since Fall 2004 to Spring 2009. SUR 815-004 University of Kentucky

Preceptor for 3rd year medical students: Clinical Clerkship: Course MD 815: September 2003 to April 2009. University of Kentucky Preceptor for 4th year medical students: Acting Internship: Course MD 815: September 2003 to April 2009. University of Kentucky

/30 3/1/17


Preceptor for 1st year medical students: Patient Centered Medicine: Course MD 815: November 2006 to May 2007. University of Kentucky Preceptor, “Surgical anatomy of abdomen”, a six-hour combined lecture and cadaver dissection course offered as an elective for first year medical student at Mount Sinai School of Medicine, April, 2001. University of Kentucky “Management of end-stage liver disease”, A two-hour lecture as a part of Gastroenterology lecture series for third year medical student at Soonchunhyang University College of Medicine. given in fall semester yearly 1998-1999

“Surgical Disease of Pancreas”, A four-hour lecture as a part of Gastroenterology lecture series for third year medical student at Soonchunhyang University College of Medicine. given in fall semester yearly 1998-1999 Coordinator, “Surgery – Radiology – Pathology conference” Soonchunhyang University College of Medicine. Biweekly 1998-1999

Continuing Medical Education CCTN Certification course, University of Illinois at Chicago, September 2010 Living donor liver transplantation in Chicago 2010. Walter Payton Liver Symposium, University of Illinois at Chicago, September 2010

Multidisciplinary managements of malignant tumor of the liver. Walter Payton Liver Symposium, University of Illinois at Chicago, September 2009 New liver allocation algorithm and its impact on our patient care – The sicker first. Transplant Update Issue 2. March 2005 “Liver transplantation for liver cancers”. Transplant Update Issue 1. Oct. 2004 Editor, “Transplant Update”. A quarterly newsletter from UK Transplant Center to referral physicians (primary care physicians, nephrologists, and gastroenterologists in Kentucky and West Virginia)

Post-graduate training Transplant Surgery Fellows Name Date Current Position Chandra Bhati, MD 7.2009 – 6.2011 Transplant Surgeon, Virginia Commonwealth

University, Richmond, VA Atul Nanda, MD 7.2011 – 6.2012 General surgeon, Norwegian American

Medical Center, Chicago, IL Arshad Khan, MD 10.2011 – 9.2013 Transplant Surgeon, University of Illinois at

Chicago, Chicago, IL

/30 3/1/17


INSTITUTIONAL SERVICE

Specialty career advisor in general surgery, Office of Student Affairs, College of Medicine, University of Illinois at Chicago, September 2011 - 2016 Admission interviewer, College of Medicine, University of Illinois at Chicago, April 2010 – Apr 2013 Admission interviewer, General Surgery Residency Program, University of Illinois at Chicago, September 2010 – 2016 Team-based faculty academic advisor, College of Medicine, University of Illinois at Chicago, September 2012 – 2015

mentored seven medical students in class of 2016 : Angelica Alonso Matthew Gust Wentao Li Garrett Schwarzman Meera Thakkar Eric Yoo Brittany Smith

Fellow, The Honors College, University of Illinois at Chicago, March 2010 – 2016 84. Garcia-Roca R, Tzvetanov IG, Jeon H, Hetterman E, Oberholzer J, Benedetti E.

Faculty academic advisor, College of Medicine, University of Illinois at Chicago Previous Advisees: Eric Kirshenbaum, MD 2009-2013, Resident in Urology, Loyola University Stacy J. Kim, MD 2009-2013, Resident in Radiology, Saint Louis University

COMMUNITY AND SOCIAL SERVICE

Board Member, Lexington Korean School: July 2004 – 2010 Advisory Board Member, Korean American Community Services, Community Health programs (4300 N. California Ave.,Chicago, IL 60618): December 2009 – 2013 Executive Board Member: Korean American Community Services (4300 N. California Ave.,Chicago, IL 60618): July 2010 – 2014 Advisory Board Member, Asian Health Coalitions of Illinois: July 2010 – 2012 (180 W. Washington Street, Suite 1000, Chicago, IL 60602 ) Medical Advisory Board Member, American Liver Foundation Great Lakes Division, April 2010 - 2017

/30 3/1/17

hoonbae jeon, md curriculum vitae

Documents